A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand

Journal of Immunology

Volumn 188, Issue 7, 2012, Pages 3188-3198

  Ray, Avijit ^a   Basu, Sreemanti ^a,b   Williams, Calvin B ^b   Salzman, Nita H ^b   Dittel, Bonnie N ^a,b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; GLUCOCORTICOID; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; COLITIS; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOIMMUNITY; B-LYMPHOCYTES; B7 ANTIGENS; COCULTURE TECHNIQUES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HOMEOSTASIS; INTERLEUKIN-10; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SPLEEN; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTORS;

EID: 84859376769     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103354     Document Type: Article

References (57)

1. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278. (Pubitemid 27023727)
2. Ray, A., M. K. Mann, S. Basu, and B. N. Dittel. 2011. A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neuroimmunol. 230: 1-9.
3. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950. (Pubitemid 35154008)
4. Mauri, C. 2010. Regulation of immunity and autoimmunity by B cells. Curr. Opin. Immunol. 22: 761-767.
5. Matsushita, T., K. Yanaba, J. D. Bouaziz, M. Fujimoto, and T. F. Tedder. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118: 3420-3430.
6. Hauser, S. L., E. Waubant, D. L. Arnold, T. Vollmer, J. Antel, R. J. Fox, A. Bar-Or, M. Panzara, N. Sarkar, S. Agarwal, et al and HERMES Trial Group. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688. (Pubitemid 351240747)
7. Bar-Or, A., P. A. Calabresi, D. Arnold, C. Markowitz, S. Shafer, L. H. Kasper, E.Waubant, S. Gazda, R. J. Fox, M. Panzara, et al. 2008. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial. [Published erratum appears in 2008 Ann. Neurol. 63: 803.] Ann. Neurol. 63: 395-400. (Pubitemid 351499869)
8. Dass, S., E. M. Vital, and P. Emery. 2007. Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum. 56: 2715-2718. (Pubitemid 47237290)
9. Goetz, M., R. Atreya, M. Ghalibafian, P. R. Galle, and M. F. Neurath. 2007. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm. Bowel Dis. 13: 1365-1368. (Pubitemid 350206846)
10. El Fassi, D., C. H. Nielsen, J. Kjeldsen, O. Clemmensen, and L. Hegedüs. 2008. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease. Gut 57: 714-715. (Pubitemid 351579988)
11. Mielke, F., J. Schneider-Obermeyer, and T. Dörner. 2008. Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma. Ann. Rheum. Dis. 67: 1056-1057. (Pubitemid 351956683)
12. Rudensky, A. Y. 2011. Regulatory T cells and Foxp3. Immunol. Rev. 241: 260-268.
13. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
14. + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178: 3447-3456.
15. Matsushita, T., M. Horikawa, Y. Iwata, and T. F. Tedder. 2010. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 185: 2240-2252.
16. Sun, J. B., C. F. Flach, C. Czerkinsky, and J. Holmgren. 2008. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J. Immunol. 181: 8278-8287.
17. Weber, M. S., T. Prod'homme, J. C. Patarroyo, N. Molnarfi, T. Karnezis, K. Lehmann-Horn, D. M. Danilenko, J. Eastham-Anderson, A. J. Slavin, C. Linington, et al. 2010. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann. Neurol. 68: 369-383.
18. Zhong, X., W. Gao, N. Degauque, C. Bai, Y. Lu, J. Kenny, M. Oukka, T. B. Strom, and T. L. Rothstein. 2007. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur. J. Immunol. 37: 2400-2404. (Pubitemid 47423610)
19. + Treg population via TGF-beta3. Eur. J. Immunol. 38: 2488-2498.
20. Carter, N. A., R. Vasconcellos, E. C. Rosser, C. Tulone, A. Muñoz-Suano, M. Kamanaka, M. R. Ehrenstein, R. A. Flavell, and C. Mauri. 2011. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 186: 5569-5579.
21. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162: 5317-5326.
22. Darrasse-Jèze, G., S. Deroubaix, H. Mouquet, G. D. Victora, T. Eisenreich, K. H. Yao, R. F. Masilamani, M. L. Dustin, A. Rudensky, K. Liu, and M. C. Nussenzweig. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206: 1853-1862.
23. van Olffen, R. W., N. Koning, K. P. van Gisbergen, F. M. Wensveen, R. M. Hoek, L. Boon, J. Hamann, R. A. van Lier, and M. A. Nolte. 2009. GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo. J. Immunol. 182: 7490-7500.
24. Nocentini, G., and C. Riccardi. 2009. GITR: a modulator of immune response and inflammation. Adv. Exp. Med. Biol. 647: 156-173.
25. Haribhai, D., W. Lin, L. M. Relland, N. Truong, C. B. Williams, and T. A. Chatila. 2007. Regulatory T cells dynamically control the primary immune response to foreign antigen. J. Immunol. 178: 2961-2972. (Pubitemid 46333175)
26. + T cell reactivity. J. Immunol. 180: 4994-5003.
27. Dittel, B. N. 2010. Depletion of specific cell populations by complement depletion. J. Vis. Exp. 36: 1487.
28. Goverman, J., A. Woods, L. Larson, L. P. Weiner, L. Hood, and D. M. Zaller. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551-560. (Pubitemid 23077743)
29. Lafaille, J. J., K. Nagashima, M. Katsuki, and S. Tonegawa. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient antimyelin basic protein T cell receptor transgenic mice. Cell 78: 399-408. (Pubitemid 24250805)
30. Brabb, T., A. W. Goldrath, P. von Dassow, A. Paez, H. D. Liggitt, and J. Goverman. 1997. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. J. Immunol. 159: 497-507. (Pubitemid 127493737)
31. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin- 10-deficient mice develop chronic enterocolitis. Cell 75: 263-274. (Pubitemid 23320290)
32. Furtado, G. C., M. A. Curotto de Lafaille, N. Kutchukhidze, and J. J. Lafaille. 2002. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196: 851-857.
33. Homann, D., A. Tishon, D. P. Berger, W. O. Weigle, M. G. von Herrath, and M. B. Oldstone. 1998. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. J. Virol. 72: 9208-9216. (Pubitemid 28471867)
34. Bergmann, C. C., C. Ramakrishna, M. Kornacki, and S. A. Stohlman. 2001. Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection. J. Immunol. 167: 1575-1583. (Pubitemid 32703158)
35. Shimoda, M., F. Mmanywa, S. K. Joshi, T. Li, K. Miyake, J. Pihkala, J. A. Abbas, and P. A. Koni. 2006. Conditional ablation of MHC-II suggests an indirect role for MHC-II in regulatory CD4 T cell maintenance. J. Immunol. 176: 6503-6511. (Pubitemid 43787832)
36. Chang, C. H., S. Guerder, S. C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4: 167-178. (Pubitemid 26093162)
37. Tone, M., Y. Tone, E. Adams, S. F. Yates, M. R. Frewin, S. P. Cobbold, and H. Waldmann. 2003. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100: 15059-15064. (Pubitemid 37518016)
38. Criswell, L. A., K. A. Pfeiffer, R. F. Lum, B. Gonzales, J. Novitzke, M. Kern, K. L. Moser, A. B. Begovich, V. E. Carlton, W. Li, et al. 2005. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 76: 561-571. (Pubitemid 40432164)
39. Audia, S., M. Samson, J. Guy, N. Janikashvili, J. Fraszczak, M. Trad, M. Ciudad, V. Leguy, S. Berthier, T. Petrella, et al. 2011. Immunologic effects of rituximab on the human spleen in immune thrombocytopenia. Blood 118: 4394-4400.
40. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
41. + regulatory T cell function. Science 322: 271-275.
42. + regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J. Exp. Med. 206: 421-434.
43. + regulatory T cells abrogates their function in vivo. J. Immunol. 177: 4376-4383.
44. Gavin, M. A., S. R. Clarke, E. Negrou, A. Gallegos, and A. Rudensky. 2002. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3: 33-41. (Pubitemid 34065615)
45. Pöllinger, B., G. Krishnamoorthy, K. Berer, H. Lassmann, M. R. Bösl, R. Dunn, H. S. Domingues, A. Holz, F. C. Kurschus, and H. Wekerle. 2009. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 206: 1303-1316.
46. + T cells. PLoS ONE 5: e15372.
47. Frommer, F., T. J. Heinen, F. T. Wunderlich, N. Yogev, T. Buch, A. Roers, E. Bettelli, W. Müller, S. M. Anderton, and A. Waisman. 2008. Tolerance without clonal expansion: self-antigen-expressing B cells program self-reactive T cells for future deletion. J. Immunol. 181: 5748-5759.
48. Raddassi, K., S. C. Kent, J. Yang, K. Bourcier, E. M. Bradshaw, V. Seyfert-Margolis, G. T. Nepom, W. W. Kwok, and D. A. Hafler. 2011. Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis. J. Immunol. 187: 1039-1046.
49. Yanaba, K., A. Yoshizaki, Y. Asano, T. Kadono, T. F. Tedder, and S. Sato. 2011. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 178: 735-743.
50. Dittel, B. N., R. M. Merchant, and C. A. Janeway, Jr. 1999. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 162: 6392-6400. (Pubitemid 29309359)
51. Barr, T. A., S. Brown, G. Ryan, J. Zhao, and D. Gray. 2007. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37: 3040-3053. (Pubitemid 350131284)
52. Lampropoulou, V., K. Hoehlig, T. Roch, P. Neves, E. Calderón Gómez, C. H. Sweenie, Y. Hao, A. A. Freitas, U. Steinhoff, S. M. Anderton, and S. Fillatreau. 2008. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180: 4763-4773.
53. -/-) mice. J. Immunol. 184: 212-221.
54. Cua, D. J., H. Groux, D. R. Hinton, S. A. Stohlman, and R. L. Coffman. 1999. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189: 1005-1010. (Pubitemid 29149357)
55. Yanaba, K., J. D. Bouaziz, T. Matsushita, T. Tsubata, and T. F. Tedder. 2009. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J. Immunol. 182: 7459-7472.
56. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230. (Pubitemid 34211962)
57. Hamel, K. M., Y. Cao, S. Ashaye, Y. Wang, R. Dunn, M. R. Kehry, T. T. Glant, and A. Finnegan. 2011. B cell depletion enhances T regulatory cell activity essential in the suppression of arthritis. J. Immunol. 187: 4900-4906.